{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:56:46Z","timestamp":1760608606825},"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T00:00:00Z","timestamp":1281571200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1000883","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T19:52:07Z","timestamp":1281642727000},"page":"e1000883","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Computational Models of HIV-1 Resistance to Gene Therapy Elucidate Therapy Design Principles"],"prefix":"10.1371","volume":"6","author":[{"given":"Sharon","family":"Aviran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David V.","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam P.","family":"Arkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMp0806162","article-title":"An HIV Vaccine \u2013 Challenges and Prospects.","volume":"359","author":"MI Johnston","year":"2008","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":"The Challenge of Finding a Cure for HIV Infection.","volume":"323","author":"DD Richman","year":"2009","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"HIV Drug Resistance.","volume":"350","author":"F Clavel","year":"2004","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nbt1367","article-title":"Genetic therapies against HIV.","volume":"25","author":"JJ Rossi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.0608138103","article-title":"Gene transfer in humans using a conditionally replicating lentiviral vector.","volume":"103","author":"BL Levine","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/mt.sj.6300124","article-title":"Transfer of Autologous Gene-modified T Cells in HIV-infected Patients with Advanced Immunodeficiency and Drug-resistant Virus.","volume":"15","author":"J van Lunzen","year":"2007","journal-title":"Mol Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/hum.2005.16.1065","article-title":"Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals.","volume":"16","author":"RA Morgan","year":"2005","journal-title":"Hum Gene Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0684.2006.00172.x","article-title":"Can gene delivery close the door to HIV-1 entry after escape?","volume":"35","author":"CH Swan","year":"2006","journal-title":"J Med Primatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/JVI.78.5.2601-2605.2004","article-title":"Human Immunodeficiency Virus Type 1 Escapes from RNA Interference-Mediated Inhibition.","volume":"78","author":"AT Das","year":"2004","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1128\/JVI.00666-08","article-title":"Mutations in gp120 Contribute to the Resistance of Human Immunodeficiency Virus Type 1 to Membrane-Anchored C-Peptide maC46.","volume":"83","author":"FG Hermann","year":"2009","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1128\/JVI.78.13.7079-7088.2004","article-title":"Antisense-Mediated Inhibition of Human Immunodeficiency Virus (HIV) Replication by Use of an HIV Type 1-Based Vector Results in Severely Attenuated Mutants Incapable of Developing Resistance.","volume":"78","author":"X Lu","year":"2004","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ymthe.2006.07.007","article-title":"Silencing of HIV-1 with RNA interference: a multiple shRNA approach.","volume":"14","author":"O ter Brake","year":"2006","journal-title":"Mol Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ymthe.2005.07.524","article-title":"Long-Term Inhibition of HIV-1 Infection in Primary Hematopoietic Cells by Lentiviral Vector Delivery of a Triple Combination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy.","volume":"12","author":"M-J Li","year":"2005","journal-title":"Mol Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.gt.3302977","article-title":"Progress and prospects: RNA-based therapies for treatment of HIV infection.","volume":"14","author":"L Scherer","year":"2007","journal-title":"Gene Ther"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.2307\/j.ctvjghw98","article-title":"Evolutionary dynamics: exploring the equations of life","author":"MA Nowak","year":"2006"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198504184.001.0001","article-title":"Virus dynamics: mathematical principles of immunology and virology","author":"MA Nowak","year":"2000"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri700","article-title":"Modelling viral and immune system dynamics.","volume":"2","author":"AS Perelson","year":"2002","journal-title":"Nat Rev Immun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/MMBR.65.1.151-185.2001","article-title":"Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology.","volume":"65","author":"IM Rouzine","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF02458427","article-title":"Gene therapy of T helper cells in HIV infection: Mathematical model of the criteria for clinical effect.","volume":"59","author":"O Lund","year":"1997","journal-title":"Bull Math Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"10028","DOI":"10.1128\/JVI.77.18.10028-10036.2003","article-title":"Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection.","volume":"77","author":"LS Weinberger","year":"2003","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jtbi.2005.05.005","article-title":"Impact of gene-modified T cells on HIV infection dynamics.","volume":"238","author":"D von Laer","year":"2006","journal-title":"J Theor Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1128\/JVI.79.3.1645-1654.2005","article-title":"Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.","volume":"79","author":"JN Leonard","year":"2005","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.chom.2008.09.008","article-title":"HIV evades RNA interference directed at TAR by an indirect compensatory mechanism.","volume":"4","author":"JN Leonard","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/hum.2006.17.577","article-title":"Gene-Based Immunotherapy for Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome.","volume":"17","author":"B Dropulic","year":"2006","journal-title":"Hum Gene Ther"},{"key":"ref25","first-page":"265","article-title":"Antiviral Gene Therapy","author":"D von Laer","year":"2009"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment-Naive Populations and Associate with Reduced Treatment Efficacy.","volume":"5","author":"JA Johnson","year":"2008","journal-title":"PLoS Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jmv.21139","article-title":"Updated prevalence of genotypic resistance among HIV-1 positive patients na\u00efve to antiretroviral therapy: a single center analysis.","volume":"80","author":"G Lapadula","year":"2008","journal-title":"J Med Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.1073\/pnas.0705474104","article-title":"Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates.","volume":"104","author":"DS An","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1742-4690-2-53","article-title":"CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.","volume":"2","author":"J Anderson","year":"2005","journal-title":"Retrovirology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nbt1410","article-title":"Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.","volume":"26","author":"EE Perez","year":"2008","journal-title":"Nat Biotechnol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/sj.gt.3302801","article-title":"T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.","volume":"13","author":"CH Swan","year":"2006","journal-title":"Gene Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.gt.3302413","article-title":"T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120.","volume":"12","author":"S Masiero","year":"2004","journal-title":"Gene Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1128\/JVI.00270-06","article-title":"Removal of Arginine 332 Allows Human TRIM5\u03b1 To Bind Human Immunodeficiency Virus Capsids and To Restrict Infection.","volume":"80","author":"Y Li","year":"2006","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nri2635","article-title":"Engineering lymphocyte subsets: tools, trials and tribulations.","volume":"9","author":"CH June","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12026-008-8070-9","article-title":"Adoptive immunotherapy: good habits instilled at youth have long-term benefits.","volume":"42","author":"C Paulos","year":"2008","journal-title":"Immunol Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"36ra43","DOI":"10.1126\/scitranslmed.3000931","article-title":"Safety and feasibility of lentiviral vector-modified CD34+ cells in the setting of autologous transplantation for AIDS-related lymphoma.","volume":"2","author":"DL DiGiusto","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jtbi.1995.0165","article-title":"Towards a general function describing t cell proliferation.","volume":"175","author":"RJ De Boer","year":"1995","journal-title":"J Theor Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.","volume":"271","author":"AS Perelson","year":"1996","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jtbi.2009.06.011","article-title":"Modeling HIV persistence, the latent reservoir, and viral blips.","volume":"260","author":"L Rong","year":"2009","journal-title":"J Theor Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrmicro772","article-title":"HIV-1 dynamics in vivo: implications for therapy.","volume":"1","author":"V Simon","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/gt.2009.118","article-title":"Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo.","volume":"17","author":"H-P Kiem","year":"2010","journal-title":"Gene Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jgm.908","article-title":"Gene therapy for HIV infection: what does it need to make it work?","volume":"8","author":"D von Laer","year":"2006","journal-title":"J Gene Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/JVI.78.2.568-575.2004","article-title":"Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides.","volume":"78","author":"M Egelhofer","year":"2004","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/hum.2006.158","article-title":"Protein Scaffold and Expression Level Determine Antiviral Activity of Membrane-Anchored Antiviral Peptides.","volume":"20","author":"FG Hermann","year":"2009","journal-title":"Hum Gene Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1440-1711.2003.01191.x","article-title":"Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty.","volume":"81","author":"JM Murray","year":"2003","journal-title":"Immunol Cell Biol"},{"key":"ref46","first-page":"167","article-title":"Age, T-cell Homeostasis, and T-cell Diversity in Humans","author":"DL Lamar","year":"2009"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.4049\/jimmunol.167.11.6663","article-title":"Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection.","volume":"167","author":"DC Douek","year":"2001","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM199501193320303","article-title":"Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy.","volume":"332","author":"CL Mackall","year":"1995","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1554\/0014-3820(2000)054[0686:EODMAO]2.0.CO;2","article-title":"Effect of Deleterious Mutation-Accumulation on the Fitness of RNA Bacteriophage MS2.","volume":"54","author":"Mdl Pena","year":"2000","journal-title":"Evolution"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1371\/journal.pbio.0030381","article-title":"Evolution of Mutational Robustness in an RNA Virus.","volume":"3","author":"R Montville","year":"2005","journal-title":"PLoS Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1073\/pnas.032668599","article-title":"Redundancy, antiredundancy, and the robustness of genomes.","volume":"99","author":"DC Krakauer","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/JVI.78.2.603-611.2004","article-title":"Competitive Fitness of Nevirapine-Resistant Human Immunodeficiency Virus Type 1 Mutants.","volume":"78","author":"JA Collins","year":"2004","journal-title":"J Virol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1126\/science.1101786","article-title":"Evidence for Positive Epistasis in HIV-1.","volume":"306","author":"S Bonhoeffer","year":"2004","journal-title":"Science"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2005.07.003","article-title":"Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir.","volume":"68","author":"L Doyon","year":"2005","journal-title":"Antiviral Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1128\/JVI.71.6.4479-4484.1997","article-title":"Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.","volume":"71","author":"J Goudsmit","year":"1997","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1128\/JVI.74.23.11067-11072.2000","article-title":"Estimating relative fitness in viral competition experiments.","volume":"74","author":"AFM Maree","year":"2000","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/JVI.80.5.2380-2389.2006","article-title":"Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay.","volume":"80","author":"H Wu","year":"2006","journal-title":"J Virol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/CMR.00017-07","article-title":"Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness.","volume":"20","author":"C Dykes","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jps.10286","article-title":"Barriers to nonviral gene delivery.","volume":"92","author":"CM Wiethoff","year":"2003","journal-title":"J Pharm Sci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/sj.gt.3302645","article-title":"Antiviral RNAi therapy: emerging approaches for hitting a moving target.","volume":"13","author":"JN Leonard","year":"2005","journal-title":"Gene Ther"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2006.05.015","article-title":"Optimization and Functional Effects of Stable Short Hairpin RNA Expression in Primary Human Lymphocytes via Lentiviral Vectors.","volume":"14","author":"DS An","year":"2006","journal-title":"Mol Ther"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/eji.200838594","article-title":"Expression of IL-15RA or an IL-15\/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis.","volume":"39","author":"J Rowley","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1091903","article-title":"MicroRNAs Modulate Hematopoietic Lineage Differentiation.","volume":"303","author":"C-Z Chen","year":"2004","journal-title":"Science"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.4049\/jimmunol.173.10.6303","article-title":"Genetic Manipulation of Telomerase in HIV-Specific CD8+ T Cells: Enhanced Antiviral Functions Accompany the Increased Proliferative Potential and Telomere Length Stabilization.","volume":"173","author":"M Dagarag","year":"2004","journal-title":"J Immunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.4049\/jimmunol.175.11.7226","article-title":"Primary Human T Lymphocytes Engineered with a Codon-Optimized IL-15 Gene Resist Cytokine Withdrawal-Induced Apoptosis and Persist Long-Term in the Absence of Exogenous Cytokine.","volume":"175","author":"C Hsu","year":"2005","journal-title":"J Immunol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2004-10-4144","article-title":"Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.","volume":"106","author":"A Roth","year":"2005","journal-title":"Blood"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways.","volume":"441","author":"D Grimm","year":"2006","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1093\/nar\/gkm543","article-title":"Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC.","volume":"35","author":"D Castanotto","year":"2007","journal-title":"Nucl Acids Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1172\/JCI8647","article-title":"Factors influencing T-cell turnover in HIV-1-seropositive patients.","volume":"105","author":"JM McCune","year":"2000","journal-title":"J Clin Invest"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"15572","DOI":"10.1073\/pnas.242358099","article-title":"In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted?","volume":"99","author":"RM Ribeiro","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nm.1932","article-title":"Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.","volume":"15","author":"RT Mitsuyasu","year":"2009","journal-title":"Nat Med"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood-2005-06-2335","article-title":"Survival of the fittest: in vivo selection and stem cell gene therapy.","volume":"107","author":"T Neff","year":"2006","journal-title":"Blood"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/gt.2009.133","article-title":"Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K.","volume":"17","author":"P Maier","year":"2010","journal-title":"Gene Ther"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"e7693","DOI":"10.1371\/journal.pone.0007693","article-title":"Protection of Stem Cell-Derived Lymphocytes in a Primate AIDS Gene Therapy Model after In Vivo Selection.","volume":"4","author":"GD Trobridge","year":"2009","journal-title":"PLoS One"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.317.5838.612","article-title":"Building an HIV-Proof Immune System.","volume":"317","author":"J Cohen","year":"2007","journal-title":"Science"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/bies.10386","article-title":"Recombination in HIV and the evolution of drug resistance: for better or for worse?","volume":"26","author":"MT Bretscher","year":"2004","journal-title":"Bioessays"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"e1000305","DOI":"10.1371\/journal.pcbi.1000305","article-title":"Timing the emergence of resistance to anti-HIV drugs with large genetic barriers.","volume":"5","author":"P Arora","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1089\/hum.2005.16.1355","article-title":"Hematopoietic Stem Cell Transduction and Amplification in Large Animal Models.","volume":"16","author":"G Trobridge","year":"2005","journal-title":"Hum Gene Ther"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1471-4914(02)02415-2","article-title":"Thymic regeneration: teaching an old immune system new tricks.","volume":"8","author":"SP Berzins","year":"2002","journal-title":"Trends Mol Med"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nri853","article-title":"Maintaining the norm: T-cell homeostasis.","volume":"2","author":"SC Jameson","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.180.4.2240","article-title":"Comprehensive Assessment and Mathematical Modeling of T Cell Population Dynamics and Homeostasis.","volume":"180","author":"V Thomas-Vaslin","year":"2008","journal-title":"J Immunol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ymthe.2005.05.014","article-title":"T Lymphocytes Transduced with a Lentiviral Vector Expressing F12-vif Are Protected from HIV-1 Infection in an APOBEC3G-Independent Manner.","volume":"12","author":"G Vallanti","year":"2005","journal-title":"Mol Ther"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection.","volume":"373","author":"X Wei","year":"1995","journal-title":"Nature"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1-infected compartments during combination therapy.","volume":"387","author":"AS Perelson","year":"1997","journal-title":"Nature"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.1073\/pnas.97.14.7681","article-title":"Production of resistant HIV mutants during antiretroviral therapy.","volume":"97","author":"RM Ribeiro","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1371\/journal.pcbi.0030133","article-title":"Optimal timing and duration of induction therapy for HIV-1 infection.","volume":"3","author":"ME Curlin","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1128\/JVI.00712-06","article-title":"Genotypic Changes in Human Immunodeficiency Virus Type 1 Protease Associated with Reduced Susceptibility and Virologic Response to the Protease Inhibitor Tipranavir.","volume":"80","author":"JD Baxter","year":"2006","journal-title":"J Virol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0140-6736(99)02035-8","article-title":"Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis.","volume":"354","author":"B Ramratnam","year":"1999","journal-title":"Lancet"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/JVI.69.8.5087-5094.1995","article-title":"Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.","volume":"69","author":"L Mansky","year":"1995","journal-title":"J Virol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/4772","article-title":"Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.","volume":"5","author":"M Hellerstein","year":"1999","journal-title":"Nat Med"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T11:53:35Z","timestamp":1711713215000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000883"}},"subtitle":[],"editor":[{"given":"Sergei L.","family":"Kosakovsky Pond","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,12]]},"references-count":90,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1000883","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,12]]}}}